A Case of Hemolytic Uremic Syndrome in a 10-Year-Old Male With Severe Neurologic Involvement Successfully Treated With Eculizumab

• Auteurs principaux: Malia Rasa MD (Auteur), James Musgrave MD (Auteur), Keith Abe MD (Auteur), Len Tanaka MD (Auteur), Konstantine Xoinis MD (Auteur), Bruce Shiramizu MD (Auteur), Gretchen Foskett MD (Auteur), Rhiana Lau MD (Auteur)
• Format: Livre
• Publié: SAGE Publishing, 2017-11-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

Hemolytic uremic syndrome (HUS) can be classified as typical and atypical, and the treatment recommendations currently differ between the 2 types. Eculizumab is recommended as first-line treatment for atypical HUS; however, its use in typical HUS has been controversial. We report a case of a 10-year...